113 related articles for article (PubMed ID: 9434450)
1. [Oral hypoglycemic agents--overview].
Sakamoto N; Uno T
Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
[No Abstract] [Full Text] [Related]
2. [Measures to meet the side effects of the orally administered antihyperglycemic drugs].
Ishii J; Inoue I
Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452
[No Abstract] [Full Text] [Related]
3. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Kitaoka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
[No Abstract] [Full Text] [Related]
4. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
Kitaoka H
Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
[No Abstract] [Full Text] [Related]
5. [Adverse effects of oral hypoglycemic agents].
Mori Y; Sekihara H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
[No Abstract] [Full Text] [Related]
6. [Combination therapy with biguanides].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
[No Abstract] [Full Text] [Related]
7. [Selection of oral antidiabetic drugs].
Iwamoto Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():428-32. PubMed ID: 15779417
[No Abstract] [Full Text] [Related]
8. [Pharmacologic profile of oral antidiabetic agents].
Okubo M; Yamane K; Kohno N
Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
[No Abstract] [Full Text] [Related]
9. [Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
Kawamori R; Kadowaki T; Ishida H
Nihon Rinsho; 2004 Apr; 62(4):831-9. PubMed ID: 15106356
[No Abstract] [Full Text] [Related]
10. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Rybka J
Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869
[TBL] [Abstract][Full Text] [Related]
11. [Sulfonylurea and alpha-glucosidase inhibitor].
Iijima T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
[No Abstract] [Full Text] [Related]
12. Pharmacologic management of diabetes mellitus.
Mozersky RP
J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
[TBL] [Abstract][Full Text] [Related]
13. Different effects of acarbose and voglibose on serum 1,5-anhydroglucitol concentrations.
Sakane N; Yoshida T; Kogure A; Kondo M
Diabetes Care; 1998 Mar; 21(3):465-6. PubMed ID: 9540040
[No Abstract] [Full Text] [Related]
14. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.
Haffner SM
Endocr Rev; 1998 Oct; 19(5):583-92. PubMed ID: 9793758
[No Abstract] [Full Text] [Related]
15. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
Cheng AY; Fantus IG
CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
[TBL] [Abstract][Full Text] [Related]
16. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
Odaka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024
[No Abstract] [Full Text] [Related]
17. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
Bressler R; Johnson DG
Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of type 2 diabetes.
Hermans MP; Buysschaert M
Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
[No Abstract] [Full Text] [Related]
20. Oral hypoglycemic agents: the pharmacological basis of their clinical use.
Davidoff F
R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221
[No Abstract] [Full Text] [Related]
[Next] [New Search]